We are live on ! Find out more
MYGN icon

Myriad Genetics

264 hedge funds and large institutions have $2.22B invested in Myriad Genetics in 2018 Q4 according to their latest regulatory filings, with 31 funds opening new positions, 110 increasing their positions, 74 reducing their positions, and 50 closing their positions.

New
Increased
Maintained
Reduced
Closed

49% more repeat investments, than reductions

Existing positions increased: 110 | Existing positions reduced: 74

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

4.23% less ownership

Funds ownership: 106.52%102.29% (-4.2%)

7% less funds holding

Funds holding: 284264 (-20)

36% less capital invested

Capital invested by funds: $3.48B → $2.22B (-$1.26B)

38% less first-time investments, than exits

New positions opened: 31 | Existing positions closed: 50

57% less call options, than puts

Call options by funds: $2.43M | Put options by funds: $5.67M

Holders
264
Holders Change
-20
Holders Change %
-7.04%
% of All Funds
5.88%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
31
Increased
110
Reduced
74
Closed
50
Calls
$2.43M
Puts
$5.67M
Net Calls
-$3.23M
Net Calls Change
+$9.06M
Name Holding Trade Value Shares
Change
Change in
Stake
Tudor Investment Corp
76
Tudor Investment Corp
Connecticut
$2.21M +$753K +20,924 +38%
Stifel Financial
77
Stifel Financial
Missouri
$2.14M +$478K +13,285 +22%
FPC
78
Falcon Point Capital
California
$2.09M +$2.59M +71,927 New
SEC
79
Seven Eight Capital
New York
$2.04M +$1.36M +37,895 +118%
State of Wisconsin Investment Board
80
State of Wisconsin Investment Board
Wisconsin
$1.99M +$54K +1,500 +2%
Bank of America
81
Bank of America
North Carolina
$1.97M +$1.51M +41,993 +163%
Los Angeles Capital Management
82
Los Angeles Capital Management
California
$1.91M +$232K +6,445 +11%
Public Sector Pension Investment Board (PSP Investments)
83
Public Sector Pension Investment Board (PSP Investments)
Quebec, Canada
$1.9M -$500K -13,900 -18%
Wellington Management Group
84
Wellington Management Group
Massachusetts
$1.83M +$1.49M +41,483 +191%
GIA
85
GHP Investment Advisors
Colorado
$1.77M +$82.3K +2,289 +4%
UH
86
Unigestion Holding
Switzerland
$1.77M +$2.18M +60,735 New
UBS AM
87
UBS AM
Illinois
$1.66M +$310K +8,616 +18%
SIM
88
Spark Investment Management
New York
$1.62M -$1.19M -33,100 -37%
AIG
89
American International Group
New York
$1.6M +$81K +2,251 +4%
VOYA Investment Management
90
VOYA Investment Management
Georgia
$1.56M +$61.2K +1,700 +3%
Thrivent Financial for Lutherans
91
Thrivent Financial for Lutherans
Minnesota
$1.54M -$83.4M -2,319,634 -98%
MAG
92
Millrace Asset Group
Pennsylvania
$1.53M +$497K +13,819 +35%
GCP
93
GSA Capital Partners
United Kingdom
$1.49M +$990K +27,525 +116%
New York State Teachers Retirement System (NYSTRS)
94
New York State Teachers Retirement System (NYSTRS)
New York
$1.47M +$67.5K +1,875 +4%
Truist Financial
95
Truist Financial
North Carolina
$1.46M -$268K -7,438 -13%
State of Tennessee, Department of Treasury
96
State of Tennessee, Department of Treasury
Tennessee
$1.46M +$159K +4,423 +10%
First Trust Advisors
97
First Trust Advisors
Illinois
$1.44M -$1.35M -37,484 -43%
ISL
98
Ingalls & Snyder LLC
New York
$1.44M +$21.8K +605 +1%
TPSF
99
Texas Permanent School Fund
Texas
$1.42M +$155K +4,300 +10%
Allianz Asset Management
100
Allianz Asset Management
Germany
$1.27M -$3.64M -101,047 -70%

MYGN Hedge Fund Activity: Q4 2018 in Review

264 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in Myriad Genetics (MYGN) for Q4 2018, worth a combined $2.22B — down 36% from $3.48B a quarter earlier.

Sellers outnumbered buyers: 50 funds closed out of MYGN and 31 opened new positions — a net loss of 19 holders — while 74 trimmed existing stakes and 110 added.

The largest buyer was Rice Hall James & Associates, opening a new position worth an estimated $28.8M. The largest seller was Thrivent Financial for Lutherans, cutting an estimated $83.4M.

  • 264 institutional investors held Myriad Genetics (MYGN) as of Q4 2018, down from 284 in Q3 2018.
  • Funds reported $2.22B of Myriad Genetics stock for Q4 2018, down 36% quarter-over-quarter.
  • 31 funds opened new Myriad Genetics positions in Q4 2018 and 50 closed out, a net change of -19 holders.
  • The largest Myriad Genetics buyer in Q4 2018 was Rice Hall James & Associates, an estimated $28.8M added.
  • The largest Myriad Genetics seller in Q4 2018 was Thrivent Financial for Lutherans, an estimated $83.4M sold.

Based on aggregated 13F filings for Q4 2018.